USPTO trademark

CYTOS

Under examinationUSPTOWord markClass 1Class 5Class 9Class 10+1

"CYTOS" is a word mark owned by Element Biosciences, Inc., filed at the USPTO on October 15, 2026. It is under examination and covers classes 1, 5, 9, 10 and 42.

Get this data via the API
Official USPTO record
CYTOS trademark as filed
As filed with the USPTO
Status
Under examination
Since October 15, 2026
Filed
October 15, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50164207
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns CYTOS

The owner and representative on file with the office.

Owner

Element Biosciences, Inc.

San Diego, United States

Representative

Samantha C. Markley

Loza & Loza, LLP

Goods and services

What the mark covers

The products and services CYTOS is filed for, grouped by Nice class.

  • Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes

  • Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; diagnostic reagents for medical or veterinary purposes

  • Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers

  • Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices for biomolecules and analyzers in the nature of flow-based analyzers providing cell and particle analysis, detection, or counting

  • Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; providing online non-downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online non-downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About CYTOS

Who owns the trademark "CYTOS"?

The USPTO trademark "CYTOS" (application 50164207) is owned by Element Biosciences, Inc.

What is the status of "CYTOS"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CYTOS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a144d0-bc6b-766f-bf93-297e11eb5fd3
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a144d0-bc6b-766f-bf93-297e11eb5fd3",
  "object": "trademark",
  "mark_text": "CYTOS",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50164207",
  "filing_date": "2026-10-15",
  "nice_classes": [
    1,
    5,
    9,
    10,
    42
  ],
  "owners": [
    {
      "name": "Element Biosciences, Inc.",
      "entity_id": null
    }
  ]
}